Rakovina KT-5000AI Yields Potent ATR Inhibitors in Screening
Compounds developed through collaboration with Variational AI show targeted activity Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing next-generation cancer...